iShares Neuroscience and Healthcare ETF (IBRN)

Assets	$4.50M
Expense Ratio	0.47%
PE Ratio	16.48
Shares Out	150,000
Dividend (ttm)	$0.10
Dividend Yield	0.35%
Ex-Dividend Date	Dec 17, 2024
Payout Frequency	Annual
Payout Ratio	5.73%

Volume	1,260
Open	28.47
Previous Close	29.61
Day's Range	28.47 - 29.46
52-Week Low	17.86
52-Week High	31.27
Beta	0.74
Holdings	70
Inception Date	Aug 24, 2022

About IBRN

Fund Home Page

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Region: Global
• Stock Exchange: NYSEARCA
• Ticker Symbol: IBRN
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Neuro Biopharma and MedTech Index

Top 10 Holdings

40.08% of assets

Name	Symbol	Weight
Praxis Precision Medicines, Inc.	PRAX	5.43%
Supernus Pharmaceuticals, Inc.	SUPN	4.24%
PTC Therapeutics, Inc.	PTCT	4.15%
Dyne Therapeutics, Inc.	DYN	4.02%
argenx SE	ARGX	3.86%
Axsome Therapeutics, Inc.	AXSM	3.80%
Biogen Inc.	BIIB	3.77%
Xenon Pharmaceuticals Inc.	XENE	3.67%
Catalyst Pharmaceuticals, Inc.	CPRX	3.62%
SK Biopharmaceuticals Co., Ltd.	326030	3.53%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 17, 2024	$0.10114	Dec 20, 2024
Dec 20, 2023	$0.0063	Dec 27, 2023
Jun 7, 2023	$0.00824	Jun 13, 2023

Performance

IBRN had a total return of 7.26% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.16%.